Ipratropium Bromide HFA: A Viewpoint by Maria Tsoumakidou

ISSN： 1176-3450

Source： Treatments in Respiratory Medicine, Vol.4, Iss.3, 2005-01, pp. : 221-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ipratropium Bromide HFA

By Wellington Keri

Treatments in Respiratory Medicine, Vol. 4, Iss. 3, 2005-01 ,pp. : 215-220

Adis International

Access to resources Recommend Favorite

Flunisolide HFA: A Viewpoint by Richard J. Martin

By Martin R.J.

American Journal of Respiratory Medicine, Vol. 1, Iss. 5, 2002-01 ,pp. : 373-373

Adis International

Access to resources Recommend Favorite

Comparison of Acute Bronchodilator Effects of Inhaled Ipratropium Bromide and Salbutamol in Bronchial Asthma

By Chhabra Sunil K. Pandey Kamal K.

Journal of Asthma, Vol. 39, Iss. 5, 2002-08 ,pp. : 375-381

Informa Healthcare

Access to resources Recommend Favorite

The Use of Ipratropium Bromide for the Management of Acute Asthma Exacerbation in Adults and Children: A Systematic Review

By Aaron S. Aaron Shawn

Journal of Asthma, Vol. 38, Iss. 7, 2001-10 ,pp. : 521-530

Informa Healthcare

Access to resources Recommend Favorite

A Short-Term Comparison of Fluticasone Propionate/Salmeterol with Ipratropium Bromide/Albuterol for the Treatment of COPD

By Donohue James F.

Treatments in Respiratory Medicine, Vol. 3, Iss. 3, 2004-01 ,pp. : 173-181

Adis International

Access to resources Recommend Favorite